Accordingly, we also discovered that CYP3A43 overexpression inhibits the activation of ERK1/2, which suggested that CYP3A43 overexpression suppresses NSCLC cell growth by inhibiting the ERK1/2 activation. The gene discussed is CYP3A43; the disease is non-small cell lung carcinoma.